Patents by Inventor Remon GVAN EEL

Remon GVAN EEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody-conjugates with improved therapeutic index for targeting CD30 tumours and method for improving therapeutic index of antibody-conjugates
    Patent number: 11590239
    Abstract: The present invention concerns novel and improved antibody-conjugates for targeting CD30. The inventors found that when antibody-conjugates were prepared using a specific mode of conjugation, they exhibit an improved therapeutic index.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: February 28, 2023
    Assignee: SYNAFFIX B.V.
    Inventors: Sander Sebastiaan Van Berkel, Jorge Merijn Mathieu Verkade, Maria Antonia Wijdeven, Ryan Heesbeen, Petrus Josephus Jacobus Maria Van De Sande, Remon Gvan Eel, Brian Maria Gerardus Janssen, Inge Catharina Josephina Hurkmans, Floris Louis Van Delft
  • ANTIBODY-CONJUGATES WITH IMPROVED THERAPEUTIC INDEX FOR TARGETING CD30 TUMOURS AND METHOD FOR IMPROVING THERAPEUTIC INDEX OF ANTIBODY-CONJUGATES
    Publication number: 20190262468
    Abstract: The present invention concerns novel and improved antibody-conjugates for targeting CD30. The inventors found that when antibody-conjugates were prepared using a specific mode of conjugation, they exhibit an improved therapeutic index.
    Type: Application
    Filed: February 8, 2017
    Publication date: August 29, 2019
    Inventors: Sander Sebastiaan VAN BERKEL, Jorge Merijn Mathieu VERKADE, Maria Antonia WIJDEVEN, Ryan HEESBEEN, Petrus Josephus Jacobus Maria VAN DE SANDE, Remon GVAN EEL, Brian Maria Gerardus JANSSEN, Inge Catharina Josephina HURKMANS, Floris Louis VAN DELFT